TY - JOUR
T1 - Timing of gestational diabetes diagnosis
T2 - a novel precision approach to hyperglycaemia in pregnancy?
AU - Meek, Claire L.
AU - Simmons, David
PY - 2023/11
Y1 - 2023/11
N2 - Precision medicine has offered new opportunities to improve diagnosis, prognostication and management of type 1 diabetes and type 2 diabetes but is relatively unexplored in gestational diabetes. The results of the recent Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) trial suggests that the timing of diagnosis may identify clinically relevant subtypes of gestational diabetes.1 We, here, discuss the rationale, practicalities and translational opportunities of a precision approach to gestational diabetes, which incorporates the timing of diagnosis ('early' being before 20-24weeks; 'late' being after 24 weeks).
AB - Precision medicine has offered new opportunities to improve diagnosis, prognostication and management of type 1 diabetes and type 2 diabetes but is relatively unexplored in gestational diabetes. The results of the recent Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) trial suggests that the timing of diagnosis may identify clinically relevant subtypes of gestational diabetes.1 We, here, discuss the rationale, practicalities and translational opportunities of a precision approach to gestational diabetes, which incorporates the timing of diagnosis ('early' being before 20-24weeks; 'late' being after 24 weeks).
UR - https://hdl.handle.net/1959.7/uws:76733
UR - http://www.scopus.com/inward/record.url?scp=85168439148&partnerID=8YFLogxK
UR - https://go.openathens.net/redirector/westernsydney.edu.au?url=https://doi.org/10.1111/dme.15191
U2 - 10.1111/dme.15191
DO - 10.1111/dme.15191
M3 - Article
C2 - 37528516
SN - 0742-3071
VL - 40
JO - Diabetic Medicine
JF - Diabetic Medicine
IS - 11
M1 - e15191
ER -
